PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS
Dead / Abandoned — Abandoned — failure to respond (as of 12 Jun 2020)
What this means for you
This application is over — abandoned 14 Apr 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79266965
- Mark type
- Stylized text
- Filed
- 22 May 2019
- Abandoned
- 14 Apr 2020
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of viral diseases; anti-inflammatory analgesic preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; capsules for medicines; gastro-intestinal treatment preparations; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; medical diagnostic test strips; diagnostic test reagents for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medicinal use; pharmaceuticals; clinical diagnostic reagents; pharmaceutical preparations for use in the targeted therapy of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for use in oncology; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis; radio-isotope markers for therapeutic or diagnostic use; therapeutic drugs and agents; dermatological pharmaceutical products; tumor suppressing agents; pharmaceutical preparations for respiratory organs
- Class 042 — Scientific and technological services: Research and development of vaccines and medicines; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical products development; research on the subject of pharmaceuticals; pharmaceutical products evaluation; pharmaceutical drug development services; medicine research; medical product testing; laboratory research services relating to pharmaceuticals; research in the field of medical products; consultancy in the field of testing, inspection, research of medical products; providing information on the testing, inspection, research of medical products; scientific research in the fields of medicine, health and pharmacology; consultation and providing information in the field of pharmacology; analysis and evaluation of medical product development; research in the field of target identification of tumors; research and development services in the field of medical preparations and technology for targeted therapy of tumors; research in the field of diagnostic target identification
Owner
- PLATBIO Inc., KR
Prosecution history
- 04 Jul 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 14 Jun 2021 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Jun 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 May 2021 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 14 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 14 Apr 2021 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 12 Jun 2020 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 12 Jun 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 26 Nov 2019 — ATTORNEY REVIEW COMPLETED
- 20 Nov 2019 — CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
- 15 Nov 2019 — USPTO CORRECTION PROCESSED BY IB
- 15 Nov 2019 — CORRECTION TRANSACTION RECEIVED FROM IB
- 09 Nov 2019 — REFUSAL PROCESSED BY IB
- 13 Oct 2019 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 12 Oct 2019 — REFUSAL PROCESSED BY MPU